Medicine and Dentistry
Epidermal Growth Factor Receptor
100%
Cetuximab
61%
Radiation Therapy
38%
Patient
38%
Head and Neck Squamous Cell Carcinoma
30%
Xenograft
15%
Receptor Expression
15%
Injection
15%
Diseases
7%
Lesion
7%
Specimen
7%
Complementary DNA
7%
Malignant Neoplasm
7%
Head and Neck Cancer
7%
Disease Exacerbation
7%
Adverse Event
7%
Cell Viability
7%
Intratumoral Drug Administration
7%
Plasmid DNA
7%
Antisense
7%
Evaluation Study
7%
Growth
7%
Therapeutic Procedure
7%
Experience
7%
Sense
7%
Biopsy
7%
Inpatient
7%
Cell Line
7%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Cetuximab
61%
Head and Neck Squamous Cell Carcinoma
30%
Diseases
7%
Head and Neck Cancer
7%
Adverse Event
7%
Disease Exacerbation
7%
Complementary DNA
7%
Malignant Neoplasm
7%
Plasmid DNA
7%
Death
7%